Radionetics
San Diego, US · 2 known investors
Radionetics develops small molecule radiopharmaceuticals that target GPCRs, using radioisotope-tethered ligands to image and treat cancerous tumors as part of a theranostics precision medicine approach. The company serves the oncology field with therapeutic and diagnostic radiotherapeutics and is headquartered in San Diego's life sciences community.